Business Context and Reporting Period
This Form 8-K Current Report from Nephros, Inc. covers events occurring on April 19, 2005, with the report filed on April 25, 2005. The filing details corporate governance changes, executive compensation adjustments, and amendments to the company's Certificate of Incorporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate actions rather than financial performance data.
Material Changes
- Executive Compensation: The Board approved a salary increase for Chief Financial Officer Marc L. Panoff from $140,000 to $160,000, effective retroactively to January 1, 2005.
- Board Composition: Bernard Salick, M.D., was appointed as a new director to fill a newly created vacancy. He is expected to serve on the Compensation Committee.
- Capital Structure: The Board retired all shares of Series A, Series B, Series C, and Series D Convertible Preferred Stocks. A Certificate of Retirement was filed with the Delaware Secretary of State on April 21, 2005, amending the Certificate of Incorporation to eliminate references to these preferred stock classes.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document strictly reports on the specific corporate actions listed above.
Investor Verification Checklist
- Verify the effective date of the CFO salary increase (January 1, 2005) against payroll records.
- Confirm the filing of the Certificate of Retirement with the Delaware Secretary of State.
- Review the updated Certificate of Incorporation to ensure all references to Series A through D Preferred Stock have been removed.
- Check for any undisclosed material interests involving the newly appointed director, Dr. Bernard Salick.